AI Terminal
Eckert & Ziegler Strahlen- und Medizintechnik AG
Regulatory Filings • Sep 9, 2025
130_rns_2025-09-09_2f74409a-2065-41d1-818c-ae8933a747d5.html
Regulatory Filings
Open in ViewerOpens in native device viewer
News Details
Corporate | 9 September 2025 11:30
Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
Eckert & Ziegler SE / Key word(s): Research Update
Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47%
09.09.2025 / 11:30 CET/CEST
The issuer is solely responsible for the content of this announcement.
Berlin, 9 September 2025. Eckert & Ziegler SE (ISIN DE0005659700), a leading supplier of isotope technology components for nuclear medicine and measurement technology, will be rated by the Hamburg-based private bank Joh. Berenberg, Gossler & Co. KG from now on. In their initial study, the analysts issue a “Buy” recommendation with a price target of € 24.00. This corresponds to a price potential of 46.8% compared to the Xetra closing price of € 16.35 on 8 September 2025.
The analysts emphasize in particular the strong market position of Eckert & Ziegler SE, which is benefiting from rising demand for diagnostic and therapeutic radioisotopes in nuclear medicine.
The complete research report is available in the Investors section of the company’s website :
https://www.ezag.com/investors/analyses/
About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Contributing to saving lives.
Your contact:
Eckert & Ziegler SE, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, [email protected] , www.ezag.com
09.09.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Eckert & Ziegler SE |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | +49 30 941084-138 |
| Fax: | +49 30 941084-0 |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Indices: | SDAX, TecDax, |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2194884 |
| End of News | EQS News Service |
2194884 09.09.2025 CET/CEST